Form 8-K - Current report:
SEC Accession No. 0001104659-25-079322
Filing Date
2025-08-15
Accepted
2025-08-15 17:09:01
Documents
15
Period of Report
2025-08-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2523661d1_8k.htm   iXBRL 8-K 35402
2 EXHIBIT 3.1 tm2523661d1_ex3-1.htm EX-3.1 9152
3 EXHIBIT 99.1 tm2523661d1_ex99-1.htm EX-99.1 9486
7 GRAPHIC tm2523661d1_ex99-1img01.jpg GRAPHIC 14392
  Complete submission text file 0001104659-25-079322.txt   250458

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fwbi-20250814.xsd EX-101.SCH 3026
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwbi-20250814_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwbi-20250814_pre.xml EX-101.PRE 22366
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2523661d1_8k_htm.xml XML 3802
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)